CG
AUPH icon

Cutler Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cutler Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,200
Closed -$6K – 2288
2023
Q4 		$6K Buy
+4,200
New +$34.6K ﹤0.01% 2620
2022
Q2 		– Sell
-8,400
Closed -$23K – 4945
2022
Q1 		$23K Sell
8,400
-39,900
-83% -$617K ﹤0.01% 2918
2021
Q4 		$42K Buy
48,300
+21,400
+80% +$507K ﹤0.01% 2521
2021
Q3 		$13K Buy
26,900
+12,400
+86% +$197K ﹤0.01% 3688
2021
Q2 		$16K Buy
14,500
+12,100
+504% +$154K ﹤0.01% 3479
2021
Q1 		$10K Buy
2,400
+400
+20% +$5.8K ﹤0.01% 3785
2020
Q4 		$12K Hold
2,000
– – ﹤0.01% 3047
2020
Q3 		$12K Sell
2,000
-3,000
-60% -$43.5K ﹤0.01% 2835
2020
Q2 		$18K Buy
5,000
+1,700
+52% +$27.2K ﹤0.01% 2459
2020
Q1 		$17K Buy
3,300
+300
+10% +$5.29K ﹤0.01% 2388
2019
Q4 		$10K Sell
3,000
-3,500
-54% -$32.2K ﹤0.01% 2621
2019
Q3 		$22K Buy
+6,500
New +$39.3K ﹤0.01% 2103
2018
Q3 		– Sell
-5,000
Closed -$2K – 4070
2018
Q2 		$2K Buy
+5,000
New +$27.9K ﹤0.01% 3511
2018
Q1 		– Sell
-2,300
Closed -$1K – 4423
2017
Q4 		$1K Sell
2,300
-23,000
-91% -$128K ﹤0.01% 4363
2017
Q3 		$60K Sell
25,300
-11,100
-30% -$70K ﹤0.01% 2070
2017
Q2 		$91K Sell
36,400
-41,000
-53% -$276K ﹤0.01% 1940
2017
Q1 		$201K Buy
+77,400
New +$358K 0.01% 1188

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cutler Group's AUPH Position: Q1 2024 in Review

Cutler Group sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 4,600 shares — an estimated $41K sold.

Cutler Group first reported a position in AUPH in Q4 2016 and held it in 25 quarters. The position peaked at $1.67M in Q4 2021. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Cutler Group reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 4,600 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $41K.
  • Cutler Group first reported a position in Aurinia Pharmaceuticals in Q4 2016 and held it in 25 quarters.
  • Cutler Group's Aurinia Pharmaceuticals position peaked at $1.67M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.